| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 5.87e-05 | 5 | 49 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 5.87e-05 | 5 | 49 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 5.87e-05 | 5 | 49 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 1.23e-04 | 7 | 49 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.93e-04 | 16 | 49 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions | 8.80e-04 | 18 | 49 | 2 | GO:0016722 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 9.52e-04 | 310 | 49 | 5 | GO:0030246 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.20e-03 | 21 | 49 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.71e-03 | 25 | 49 | 2 | GO:0033691 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.78e-03 | 239 | 49 | 4 | GO:0031406 | |
| GeneOntologyBiologicalProcess | iron ion transmembrane transport | 4.89e-05 | 30 | 49 | 3 | GO:0034755 | |
| GeneOntologyBiologicalProcess | iron ion import across cell outer membrane | 5.50e-05 | 5 | 49 | 2 | GO:0098706 | |
| MousePheno | diaphragmatic hernia | 5.95e-05 | 29 | 37 | 3 | MP:0003924 | |
| MousePheno | abnormal spleen development | 6.78e-05 | 5 | 37 | 2 | MP:0009323 | |
| Domain | DUF5050 | 6.47e-06 | 2 | 48 | 2 | IPR032485 | |
| Domain | DUF5050 | 6.47e-06 | 2 | 48 | 2 | PF16472 | |
| Domain | FRG2 | 1.94e-05 | 3 | 48 | 2 | PF15315 | |
| Domain | FRG2 | 1.94e-05 | 3 | 48 | 2 | IPR026245 | |
| Domain | - | 1.36e-04 | 39 | 48 | 3 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.24e-04 | 46 | 48 | 3 | IPR011042 | |
| Domain | Ferric_reduct | 4.20e-04 | 12 | 48 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 4.20e-04 | 12 | 48 | 2 | IPR013130 | |
| Domain | Quinoprot_gluc/sorb_DH | 4.20e-04 | 12 | 48 | 2 | IPR011041 | |
| Domain | Ldl_recept_b | 5.77e-04 | 14 | 48 | 2 | PF00058 | |
| Domain | LDLRB | 5.77e-04 | 14 | 48 | 2 | PS51120 | |
| Domain | LY | 6.65e-04 | 15 | 48 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.65e-04 | 15 | 48 | 2 | IPR000033 | |
| Domain | zf-CCHC | 1.58e-03 | 23 | 48 | 2 | PF00098 | |
| Domain | cEGF | 2.02e-03 | 26 | 48 | 2 | IPR026823 | |
| Domain | - | 2.02e-03 | 26 | 48 | 2 | 4.10.60.10 | |
| Domain | cEGF | 2.02e-03 | 26 | 48 | 2 | PF12662 | |
| Domain | HECT | 2.18e-03 | 27 | 48 | 2 | PF00632 | |
| Domain | HECTc | 2.18e-03 | 27 | 48 | 2 | SM00119 | |
| Domain | HECT_dom | 2.18e-03 | 27 | 48 | 2 | IPR000569 | |
| Domain | IPT | 2.18e-03 | 27 | 48 | 2 | SM00429 | |
| Domain | HECT | 2.18e-03 | 27 | 48 | 2 | PS50237 | |
| Domain | TIG | 2.87e-03 | 31 | 48 | 2 | PF01833 | |
| Domain | IPT | 3.05e-03 | 32 | 48 | 2 | IPR002909 | |
| Domain | ZF_CCHC | 3.65e-03 | 35 | 48 | 2 | PS50158 | |
| Domain | LDLR_class-A_CS | 4.74e-03 | 40 | 48 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 5.97e-03 | 45 | 48 | 2 | PF00057 | |
| Domain | - | 6.23e-03 | 46 | 48 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.77e-03 | 48 | 48 | 2 | PS01209 | |
| Domain | LDLRA_2 | 7.04e-03 | 49 | 48 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.04e-03 | 49 | 48 | 2 | IPR002172 | |
| Domain | LDLa | 7.04e-03 | 49 | 48 | 2 | SM00192 | |
| Domain | ZnF_C2HC | 8.81e-03 | 55 | 48 | 2 | SM00343 | |
| Domain | Znf_CCHC | 8.81e-03 | 55 | 48 | 2 | IPR001878 | |
| Pathway | REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS | 6.31e-05 | 5 | 36 | 2 | M27775 | |
| Pathway | REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS | 6.31e-05 | 5 | 36 | 2 | MM15514 | |
| Pubmed | The DNA sequence, annotation and analysis of human chromosome 3. | 1.98e-06 | 62 | 50 | 4 | 16641997 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.03e-06 | 2 | 50 | 2 | 15963947 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 37209327 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28724630 | ||
| Pubmed | 2.05e-06 | 1049 | 50 | 10 | 27880917 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.27e-06 | 420 | 50 | 7 | 28065597 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 3.13e-06 | 853 | 50 | 9 | 28718761 | |
| Pubmed | SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders. | 6.07e-06 | 3 | 50 | 2 | 24859880 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 30841425 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11479226 | ||
| Pubmed | The role of Siglec-G on B cells in autoimmune disease and leukemia. | 6.07e-06 | 3 | 50 | 2 | 38042621 | |
| Pubmed | The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells. | 6.07e-06 | 3 | 50 | 2 | 24790146 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19196137 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 17572677 | ||
| Pubmed | Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. | 6.07e-06 | 3 | 50 | 2 | 23836061 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 15520407 | ||
| Pubmed | Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. | 1.21e-05 | 4 | 50 | 2 | 17912374 | |
| Pubmed | Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway. | 1.21e-05 | 4 | 50 | 2 | 27398742 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 20038598 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 20200274 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 20729333 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 30143587 | ||
| Pubmed | Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. | 1.21e-05 | 4 | 50 | 2 | 24695850 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 25252961 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 24600033 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 16609065 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 36969253 | ||
| Pubmed | CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. | 2.02e-05 | 5 | 50 | 2 | 19264983 | |
| Pubmed | Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice. | 2.02e-05 | 5 | 50 | 2 | 25987743 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 32737150 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 27548433 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 26947073 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 12429817 | ||
| Pubmed | A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing. | 2.02e-05 | 5 | 50 | 2 | 21623346 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.03e-05 | 588 | 50 | 7 | 38580884 | |
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | 2.28e-05 | 38 | 50 | 3 | 11555636 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 14559209 | ||
| Pubmed | Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice. | 4.23e-05 | 7 | 50 | 2 | 15342464 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 21295565 | ||
| Pubmed | 4.34e-05 | 47 | 50 | 3 | 8812413 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 23374343 | ||
| Pubmed | 9.27e-05 | 164 | 50 | 4 | 32409323 | ||
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 1.04e-04 | 63 | 50 | 3 | 19351817 | |
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 34927784 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 24639464 | ||
| Pubmed | 1.46e-04 | 1084 | 50 | 8 | 11544199 | ||
| Pubmed | CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. | 1.56e-04 | 13 | 50 | 2 | 35921817 | |
| Pubmed | Translational animal models of autism and neurodevelopmental disorders. | 1.82e-04 | 14 | 50 | 2 | 23226954 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 15082773 | ||
| Pubmed | The septum transversum mesenchyme induces gall bladder development. | 2.10e-04 | 15 | 50 | 2 | 23951403 | |
| Pubmed | The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver. | 2.10e-04 | 15 | 50 | 2 | 22496360 | |
| Pubmed | Screening for replication of genome-wide SNP associations in sporadic ALS. | 2.40e-04 | 16 | 50 | 2 | 18987618 | |
| Pubmed | 2.40e-04 | 16 | 50 | 2 | 20347428 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.92e-04 | 1201 | 50 | 8 | 35696571 | |
| Pubmed | Assignment of 22 loci in the rat by somatic hybrid and linkage analysis. | 3.05e-04 | 18 | 50 | 2 | 8268657 | |
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 14628042 | ||
| Pubmed | Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development. | 3.05e-04 | 18 | 50 | 2 | 17425782 | |
| Pubmed | 3.53e-04 | 95 | 50 | 3 | 24029230 | ||
| Pubmed | Genome-wide association study of chronic periodontitis in a general German population. | 3.64e-04 | 96 | 50 | 3 | 24024966 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.78e-04 | 430 | 50 | 5 | 35044719 | |
| Pubmed | 3.79e-04 | 20 | 50 | 2 | 22705371 | ||
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 4.18e-04 | 21 | 50 | 2 | 27723720 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 4.18e-04 | 21 | 50 | 2 | 21337463 | |
| Pubmed | 4.34e-04 | 102 | 50 | 3 | 11214970 | ||
| Pubmed | 4.60e-04 | 104 | 50 | 3 | 10470851 | ||
| Pubmed | Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney. | 5.03e-04 | 23 | 50 | 2 | 21035938 | |
| Pubmed | 5.48e-04 | 24 | 50 | 2 | 15331780 | ||
| Pubmed | 5.95e-04 | 25 | 50 | 2 | 19149881 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 6.44e-04 | 26 | 50 | 2 | 26949039 | |
| Pubmed | A Grhl2-dependent gene network controls trophoblast branching morphogenesis. | 6.95e-04 | 27 | 50 | 2 | 25758223 | |
| Pubmed | 6.95e-04 | 27 | 50 | 2 | 26158450 | ||
| Pubmed | 7.03e-04 | 493 | 50 | 5 | 15368895 | ||
| Pubmed | Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. | 9.17e-04 | 31 | 50 | 2 | 19898483 | |
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 9.17e-04 | 31 | 50 | 2 | 23602572 | |
| Pubmed | 9.19e-04 | 1429 | 50 | 8 | 35140242 | ||
| Pubmed | 9.63e-04 | 529 | 50 | 5 | 14621295 | ||
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 1.05e-03 | 138 | 50 | 3 | 37506885 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.07e-03 | 139 | 50 | 3 | 25476789 | |
| Pubmed | 1.17e-03 | 35 | 50 | 2 | 32504627 | ||
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 1.30e-03 | 149 | 50 | 3 | 26370502 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.37e-03 | 573 | 50 | 5 | 28330616 | |
| Interaction | SIGLEC16 interactions | 5.55e-06 | 2 | 48 | 2 | int:SIGLEC16 | |
| GeneFamily | Proteases, serine|STEAP family | 3.63e-05 | 5 | 35 | 2 | 1324 | |
| GeneFamily | Low density lipoprotein receptors | 2.80e-04 | 13 | 35 | 2 | 634 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 1.06e-03 | 25 | 35 | 2 | 74 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 1.33e-03 | 28 | 35 | 2 | 745 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.71e-03 | 40 | 35 | 2 | 592 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 8.76e-06 | 398 | 49 | 7 | M14877 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-08 | 170 | 50 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-08 | 181 | 50 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-08 | 182 | 50 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-08 | 183 | 50 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-08 | 191 | 50 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.26e-06 | 168 | 50 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-06 | 182 | 50 | 5 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 183 | 50 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 187 | 50 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 187 | 50 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 188 | 50 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-06 | 189 | 50 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 190 | 50 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 190 | 50 | 5 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 197 | 50 | 5 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 138 | 50 | 4 | a88c3ae56b0af60f6e87cabade4f21e2bbb336f2 | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 2.56e-05 | 152 | 50 | 4 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.24e-05 | 173 | 50 | 4 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 4.24e-05 | 173 | 50 | 4 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 4.33e-05 | 174 | 50 | 4 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 175 | 50 | 4 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 175 | 50 | 4 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 176 | 50 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.53e-05 | 176 | 50 | 4 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 177 | 50 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.73e-05 | 178 | 50 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.94e-05 | 180 | 50 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 181 | 50 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.16e-05 | 182 | 50 | 4 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 182 | 50 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-05 | 184 | 50 | 4 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-05 | 186 | 50 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 187 | 50 | 4 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 188 | 50 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.85e-05 | 188 | 50 | 4 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-05 | 189 | 50 | 4 | f44ddb6cdbb406b0528a9b0ba3811183ab6d1fc6 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 5.97e-05 | 189 | 50 | 4 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 190 | 50 | 4 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 190 | 50 | 4 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 191 | 50 | 4 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.22e-05 | 191 | 50 | 4 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 191 | 50 | 4 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.35e-05 | 192 | 50 | 4 | 80a71ab3434076803466ccac0df73468889c7dd3 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.35e-05 | 192 | 50 | 4 | 75ce635d669ff77d1fd54e10467f21d5e5d67b08 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.35e-05 | 192 | 50 | 4 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 6.48e-05 | 193 | 50 | 4 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-05 | 193 | 50 | 4 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | MS-naiveBc|MS / Condition, Cell_class and T cell subcluster | 6.61e-05 | 194 | 50 | 4 | aa4aa0a61275610054b583f60d5d41ecc4f88a0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 50 | 4 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | MS-naiveBc-|MS / Condition, Cell_class and T cell subcluster | 6.61e-05 | 194 | 50 | 4 | 1757787246a7862f9709834efc62bac61d70b906 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 195 | 50 | 4 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-05 | 196 | 50 | 4 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.88e-05 | 196 | 50 | 4 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 6.88e-05 | 196 | 50 | 4 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-05 | 196 | 50 | 4 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-05 | 196 | 50 | 4 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-05 | 196 | 50 | 4 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 197 | 50 | 4 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 197 | 50 | 4 | 5a71e859ebe734fc70a056807b07d99fa867c687 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 7.01e-05 | 197 | 50 | 4 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 198 | 50 | 4 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 7.44e-05 | 200 | 50 | 4 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.44e-05 | 200 | 50 | 4 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | 7.44e-05 | 200 | 50 | 4 | 221dd8d8851c47f2202ba848de3a041b17b1db3f | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.44e-05 | 200 | 50 | 4 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.47e-04 | 122 | 50 | 3 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.37e-04 | 132 | 50 | 3 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.67e-04 | 135 | 50 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.88e-04 | 137 | 50 | 3 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.09e-04 | 139 | 50 | 3 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.41e-04 | 142 | 50 | 3 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 143 | 50 | 3 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | mild_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 5.52e-04 | 143 | 50 | 3 | 4698cc877dda9b1ef7d6f18c9adc869ef791b1d8 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.52e-04 | 143 | 50 | 3 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-04 | 145 | 50 | 3 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.22e-04 | 149 | 50 | 3 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.35e-04 | 150 | 50 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.35e-04 | 150 | 50 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | COVID-CD4-antiviral_CD4|COVID / Condition, Cell_class and T cell subcluster | 6.98e-04 | 155 | 50 | 3 | 7e5ae034036fe85915d38a24195501e6d3bcbfb0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 155 | 50 | 3 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 160 | 50 | 3 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-04 | 161 | 50 | 3 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-04 | 161 | 50 | 3 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-04 | 161 | 50 | 3 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-04 | 162 | 50 | 3 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.93e-04 | 162 | 50 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-04 | 162 | 50 | 3 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 8.07e-04 | 163 | 50 | 3 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.22e-04 | 164 | 50 | 3 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.22e-04 | 164 | 50 | 3 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 8.22e-04 | 164 | 50 | 3 | 7766900740f67dbbe3c4d90fbfdcc1665cee6515 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-04 | 165 | 50 | 3 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.36e-04 | 165 | 50 | 3 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.36e-04 | 165 | 50 | 3 | 7039bb5a7af4684fbd1192230864e5cd6936e83c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.36e-04 | 165 | 50 | 3 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-04 | 165 | 50 | 3 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| Disease | HEPATOCELLULAR CARCINOMA | 8.13e-05 | 9 | 45 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 8.13e-05 | 9 | 45 | 2 | cv:C2239176 | |
| Disease | asthma | 1.32e-04 | 751 | 45 | 7 | MONDO_0004979 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.49e-04 | 12 | 45 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 2.05e-04 | 14 | 45 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | nephroblastoma (is_implicated_in) | 2.05e-04 | 14 | 45 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | atopic asthma | 2.41e-04 | 199 | 45 | 4 | EFO_0010638 | |
| Disease | Congenital hernia of foramen of Morgagni | 3.83e-04 | 19 | 45 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 3.83e-04 | 19 | 45 | 2 | C0265700 | |
| Disease | Congenital diaphragmatic hernia | 4.69e-04 | 21 | 45 | 2 | C0235833 | |
| Disease | FEV/FEC ratio | 4.81e-04 | 1228 | 45 | 8 | EFO_0004713 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.14e-03 | 301 | 45 | 4 | DOID:684 (is_marker_for) | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 1.46e-03 | 37 | 45 | 2 | DOID:0050865 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQHAVLANCHFDSVA | 196 | Q7Z2K6 | |
| DFVNQCHDPNEAAHA | 311 | Q8N3J5 | |
| CHDPNEAAHAVTEQA | 316 | Q8N3J5 | |
| DDSHPVHVDNCILNA | 581 | Q32P28 | |
| HHDSQVCSNGPVSED | 361 | Q9P2P5 | |
| ADHDSSNSNCAVIVH | 236 | O75636 | |
| EDDHPHVLALDECQN | 2316 | Q9NZR2 | |
| EHDEDAGVVCSHQNP | 766 | Q96JK4 | |
| DNSDEAPALCHQHTC | 881 | Q07954 | |
| DEPSLCDCDVHKHNQ | 1076 | Q8IYD8 | |
| NGHNSDCASSPVVHE | 2541 | Q15751 | |
| PHSAIFCHDEDSSDQ | 591 | Q96RV3 | |
| NDISPLENHHCAVAF | 376 | O76083 | |
| ECAHEACNVHNLQPV | 1496 | Q6ZR08 | |
| DHVIVNDSLHDACAQ | 596 | Q96JB8 | |
| HVLANNDVSCDHPSN | 26 | Q9Y337 | |
| HCQTDQVPAWADAAH | 531 | Q8N2Q7 | |
| QEACVHQDTQAHHAL | 2776 | O95613 | |
| NNETSVMPCEDDHHL | 281 | P27694 | |
| TAVHNSEIQETCDAH | 131 | A6NGY1 | |
| AVHNSEIQETCDAHH | 131 | Q64ET8 | |
| QHPNHPDDAILQCDA | 1401 | Q8IZD9 | |
| VENHPEVAAHTSCLQ | 76 | Q8WXQ3 | |
| DQECAIHADNVNRHE | 316 | Q0VF96 | |
| CHSAPGHQEENKNDF | 111 | Q9HC77 | |
| HCIHENQTCDPEIFN | 411 | Q8NCS7 | |
| SCAHEMESVADHEPN | 1151 | Q5THK1 | |
| FPHNHTADIQSEVHC | 146 | P08581 | |
| NEHDDCQVTNPSTGH | 1511 | P11717 | |
| CVFSEEEHTQVPCHQ | 166 | Q9HBJ0 | |
| EEHTQVPCHQAGAQE | 171 | Q9HBJ0 | |
| QEINAAVEHAENPCH | 976 | Q96DN5 | |
| VCDHPDTAFTHAEEN | 1966 | Q8WUY3 | |
| NPDILTHCEHDSNSQ | 2086 | Q8WUY3 | |
| QADIHDTQAAAADEH | 651 | Q8N5C8 | |
| DVRPHHTDANNQSAC | 881 | Q9Y520 | |
| LCFDDHDPAVIHENA | 166 | Q12824 | |
| SNIHELEHEQEPTCA | 271 | Q9NP59 | |
| TDNVCHLFAEHDPEQ | 1411 | Q68CZ2 | |
| LHQTAHADEFDCPSE | 46 | Q9UHE8 | |
| HADEFDCPSELQHTQ | 51 | Q9UHE8 | |
| AHADEFDCPSELQHA | 31 | Q6NZ63 | |
| QHPEHCVTSADQHSA | 551 | Q9C0B9 | |
| AHSEVAAPCALENED | 186 | Q8TBF5 | |
| AEPHEEQCLSAFTVH | 81 | P19544 | |
| ISPNCHQELDAHEDD | 116 | Q12968 | |
| EAHVVNDHDNDANIH | 171 | Q8TCN5 | |
| AGEQHQDCEPAAAAV | 31 | Q9NPG3 | |
| HISVHPENSDCIQAD | 716 | Q5VYS8 | |
| PQDHNTDLTCHVDFS | 206 | Q96LC7 | |
| TQLGNHDSDPETCHV | 31 | A6NGD5 | |
| NCGVAFADDTDPHVH | 236 | Q96NJ3 | |
| HSAPLTTEEEDHCAN | 76 | O95405 | |
| SPQDHDTDLTCHVDF | 206 | A6NMB1 | |
| DAVPFVHAHHCNDVQ | 4231 | P20929 |